SiBone (SIBN) Competitors $16.67 +0.05 (+0.30%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$16.67 0.00 (0.00%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SIBN vs. LQDA, PRCT, LMAT, AORT, EYE, ENOV, CNMD, NVCR, SSII, and ESTAShould you be buying SiBone stock or one of its competitors? The main competitors of SiBone include Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), Artivion (AORT), National Vision (EYE), Enovis (ENOV), CONMED (CNMD), NovoCure (NVCR), SS Innovations International (SSII), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry. SiBone vs. Its Competitors Liquidia Technologies PROCEPT BioRobotics LeMaitre Vascular Artivion National Vision Enovis CONMED NovoCure SS Innovations International Establishment Labs SiBone (NASDAQ:SIBN) and Liquidia Technologies (NASDAQ:LQDA) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability. Is SIBN or LQDA more profitable? SiBone has a net margin of -12.83% compared to Liquidia Technologies' net margin of -732.17%. SiBone's return on equity of -14.20% beat Liquidia Technologies' return on equity.Company Net Margins Return on Equity Return on Assets SiBone-12.83% -14.20% -10.38% Liquidia Technologies -732.17%-232.96%-60.81% Which has preferable valuation & earnings, SIBN or LQDA? SiBone has higher revenue and earnings than Liquidia Technologies. SiBone is trading at a lower price-to-earnings ratio than Liquidia Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiBone$167.18M4.30-$30.91M-$0.56-29.77Liquidia Technologies$14M170.21-$130.39M-$1.70-16.28 Do analysts recommend SIBN or LQDA? SiBone currently has a consensus target price of $23.67, indicating a potential upside of 41.97%. Liquidia Technologies has a consensus target price of $32.11, indicating a potential upside of 16.01%. Given SiBone's higher possible upside, equities research analysts plainly believe SiBone is more favorable than Liquidia Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SiBone 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Liquidia Technologies 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in SIBN or LQDA? 98.1% of SiBone shares are held by institutional investors. Comparatively, 64.5% of Liquidia Technologies shares are held by institutional investors. 3.9% of SiBone shares are held by company insiders. Comparatively, 30.1% of Liquidia Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer SIBN or LQDA? In the previous week, Liquidia Technologies had 6 more articles in the media than SiBone. MarketBeat recorded 12 mentions for Liquidia Technologies and 6 mentions for SiBone. SiBone's average media sentiment score of 1.49 beat Liquidia Technologies' score of 1.32 indicating that SiBone is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SiBone 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Liquidia Technologies 8 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, SIBN or LQDA? SiBone has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, Liquidia Technologies has a beta of 0.22, indicating that its stock price is 78% less volatile than the S&P 500. SummarySiBone beats Liquidia Technologies on 10 of the 16 factors compared between the two stocks. Get SiBone News Delivered to You Automatically Sign up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SIBN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIBN vs. The Competition Export to ExcelMetricSiBoneMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$719.16M$7.09B$5.71B$9.76BDividend YieldN/A1.19%6.66%4.48%P/E Ratio-29.7726.1883.2526.60Price / Sales4.3071.03539.77176.71Price / CashN/A22.4425.6628.92Price / Book4.194.9610.646.08Net Income-$30.91M$176.38M$3.27B$265.93M7 Day Performance1.71%0.83%0.40%0.17%1 Month Performance-2.11%3.53%7.31%3.90%1 Year Performance0.30%7.54%46.58%19.67% SiBone Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIBNSiBone4.3452 of 5 stars$16.67+0.3%$23.67+42.0%+0.3%$719.16M$167.18M-29.77350News CoveragePositive NewsLQDALiquidia Technologies3.5447 of 5 stars$26.25-2.2%$32.11+22.3%+191.1%$2.31B$14M-15.4450Positive NewsPRCTPROCEPT BioRobotics3.4938 of 5 stars$39.31-4.7%$74.88+90.5%-49.2%$2.29B$224.50M-25.36430News CoveragePositive NewsLMATLeMaitre Vascular2.6074 of 5 stars$97.60-2.7%$97.60+5.6%$2.27B$219.86M47.38490Positive NewsAORTArtivion3.1904 of 5 stars$43.53-2.9%$40.63-6.7%+61.6%$2.12B$388.54M-103.641,600Insider TradeEYENational Vision2.8665 of 5 stars$23.93-3.6%$24.73+3.3%+117.2%$1.97B$1.82B-132.9413,411Positive NewsInsider TradeENOVEnovis4.462 of 5 stars$30.98-1.5%$51.00+64.6%-33.7%$1.80B$2.11B-2.177,367Positive NewsCNMDCONMED4.3031 of 5 stars$54.35-2.6%$59.80+10.0%-25.7%$1.73B$1.33B15.403,900News CoveragePositive NewsNVCRNovoCure4.038 of 5 stars$11.70-5.9%$28.79+146.0%-36.6%$1.39B$605.22M-7.501,488SSIISS Innovations InternationalN/A$6.98-0.1%N/AN/A$1.35B$20.65M0.004Gap UpESTAEstablishment Labs1.704 of 5 stars$40.66-6.8%$56.50+39.0%-9.9%$1.26B$166.02M-13.331,018 Related Companies and Tools Related Companies Liquidia Technologies Competitors PROCEPT BioRobotics Competitors LeMaitre Vascular Competitors Artivion Competitors National Vision Competitors Enovis Competitors CONMED Competitors NovoCure Competitors SS Innovations International Competitors Establishment Labs Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIBN) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SiBone Please log in to your account or sign up in order to add this asset to your watchlist. Share SiBone With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SIBN Stock Alerts